ICH Meeting Will Include Review Of Standardized MedDRA Grouping System
This article was originally published in The Pink Sheet Daily
Executive Summary
Data on the use of standardized MedDRA queries will be presented during the June meeting. Updates on the common technical document and expert working group progress are also slated to be discussed.
You may also be interested in...
MedDRA Electronic Adverse Event Reporting Produces Rise In Case Reports
The number of electronic reports submitted by the 13 companies using MedDRA has roughly doubled since May, CDER Senior Program Manager Andrea Feight says. FDA is working with other regulatory agencies to expand MedDRA terminology.
Lupus Guidance Suggests Broad Use Of Health-Related Quality Of Life Endpoint
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.